Research Samples Sample Clauses

Research Samples. GMP|Genetics shall notify Myriad in writing of the date (the "INITIAL ACCEPTANCE DATE") on which the laboratory at which the Conversion shall be performed (the "GMP|GENETICS Laboratory") will be ready to accept samples. The notice referred to in the immediately preceding sentence shall be given not later than fifteen (15) days prior to the Initial Acceptance Date. GMP|Genetics shall initially send to Myriad, thirty (30) specimens for full sequence analysis ("INITIAL EVALUATION"). Each specimen shall consist of a triplet: an unconverted specimen, a converted (paternal) and a converted (maternal) specimen. Myriad will perform subsequent sequencing on each of these triplet specimens. Myriad will provide GMP with copies of all test results and reports.
View Source
Research Samples. (a) In the event that Celator provides to BCCA any Research Samples for the performance of the Work: (i) Celator covenants and agrees with BCCA that it shall, upon BCCA’s request: (A) supply BCCA with documentation that describes the Research Samples and sets out any known toxicological effects, and (B) answer any questions BCCA or its investigators may have regarding the Research Samples prior to or during the performance of the Work; and (ii) BCCA covenants and agrees with Celator that it shall: (A) use all Research Samples only in compliance with all applicable laws, regulations and guidelines; (B) use each Research Sample solely in the performance of the Work and for no other purpose whatsoever; (C) not administer the Research Samples to humans and in so far as they are administered to animals, no animal to which the Research Samples are administered, or animal product derived therefrom, will be used for food, therapeutic or diagnostic purposes, or kept as a domestic pet or livestock; (D) modify, reproduce or replicate the Research Samples except as may be required for the performance of the Work; (E) not distribute or release any Research Sample or any derivative thereof to any person other than BCCA Personnel who require access to the Research Samples in the performance of the Work; (F) ensure that no BCCA Personnel shall take or send any Research Sample or any part thereof to any location, other than the BCCA facilities at which the Work is to be performed; and (G) ensure that all BCCA Personnel having access to the Research Samples are made aware of and comply with the terms of this Agreement, including the obligations of confidentiality contained herein. (b) BCCA acknowledges and agrees that the Research Samples are the property of Celator and that Celator shall retain all right, title and interest in and to the Research Samples, including all proprietary rights thereto, and nothing in this Agreement shall pass or create any right, title or interest in or to the Research Samples to or for the benefit of BCCA. BCCA shall not contest, directly or indirectly, Celator’s ownership of any Research Samples. (c) BCCA shall return any or all Research Samples in its possession or control: (i) immediately upon expiration or earlier termination of this Agreement or the applicable R&D Work Schedule, or (ii) at any time during the Term, upon 30 days prior written notice from Celator, provided that if such Research Samples are necessary for the performance of so...
View Source
Research Samples. Celator shall provide the following Research Samples to BCCA, the receipt of which shall be acknowledged in writing, in connection with the performance of the Work under the Agreement:
View Source
Research Samples 
View Source

Related to Research Samples

  • Research Program The term “

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.